Visão geral da empresa Applied Genetic Technologies
2 escritóriosLocalizações
AGTC strives to dramatically improve the lives of patients by combining science and innovation to develop gene based therapeutics. We commit ourselves to exceeding expectations for standards of integrity and open communication in all areas of our business enterprise.
AGTC is a clinical-stage biotechnology company that uses a proprietary gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. Its initial focus is in the field of ophthalmology, where it has active clinical trials in X-linked retinitis pigmentosa (XLRP) and achromatopsia (ACHM CNGB3 & ACHM CNGA3). In addition to its clinical trials, AGTC has preclinical programs in optogenetics, other ophthalmology, CNS and otology indications.
